XML 41 R24.htm IDEA: XBRL DOCUMENT v3.24.3
COMMON SHARES (Tables)
 3 Months Ended
Sep. 30, 2024
Equity [Abstract]  
The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024:

The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the three months ended September 30, 2024:

 

Date   Common Shares Issued   Gross Funds Received   Market Value of Shares Issued   (Gain)/Loss
on Issuance		 
August 28, 2024    75,000   $140   $133   $(7)
September 3, 2024    71,000    124    123    (1)
September 6, 2024    71,500    118    118    - 
September 16, 2024    72,000    124    124    - 
September 19, 2024    49,750    85    85    - 
September 25, 2024    60,000    101    108    7 
Schedule of stock option
    Number of Options   Weighted Average
Exercise Price		   Aggregate
Intrinsic Value		   Weighted
Average Remaining Life		 
Balance, June 30, 2024    2,495,500   $4.78           
Granted    -    -           
Exercised    -    -           
Cancelled/expired    (40,000)   6.95           
Balance, September 30, 2024    2,455,500   $4.76   $   -    3.22 Years 
Schedule of warrant transactions

 Schedule of warrant transactions

    Number of Warrants   Weighted Average Exercise Price 
Balance, June 30, 2024    18,563,561   $10.53 
Granted    2,816,742    2.31 
Exercised    -    - 
Expired    (447,318)   8.94 
Balance, September 30, 2024    20,932,985   $9.46 
At September 30, 2024, the Company had outstanding exercisable Warrants, as follows:

At September 30, 2024, the Company had outstanding exercisable Warrants, as follows: 

 

Number   Exercise Price   Expiry Date
 855,800   C$9.70   February 19, 2025
 250,000   $4.60   September 1, 2025
 413,432   $3.54   December 22, 2025
 315,000   $2.20   June 24, 2026
 615,385   $3.25   April 12, 2027
 15,666,626   $11.50   March 17, 2028
 2,816,742   $2.31   September 17, 2028
 20,932,985        
The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model:

The Company classifies Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are based on observable data points. The following observable data points were used in calculating the fair value of the Private Warrants using a Black Scholes pricing model:

 

Key Valuation Input  September 30,
2024		   June 30,
 2024		 
Closing Common Share price  $2.18   $1.73 
Strike price  $11.50   $11.50 
Implied volatility of Public Warrants   60%   69.0%
Risk free rate   3.58%   4.45%
Dividend yield   0%   0%
Expected warrant life in years   3.5    3.7 
The change in the Private Warrants liability is presented below:

The change in the Private Warrants liability is presented below:

 

   For the Three Months Ended September 30, 2024 
Fair value at June 30, 2024  $1,353 
Change in fair value   (205)
Fair value at September 30, 2024  $1,148 
The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:

The Company valued the Contingent Consent Warrants at $2,262 based on a Black Scholes valuation with the following inputs:

Key Valuation Input  September 17,
2024		 
Closing Common Share price  $1.74 
Term (years)   4.0 
Historic equity volatility   67.14%
Risk-free rate   3.44%